International Linked Clinical Trials (iLCT)
26 results.
Grand Rapids, Mich. (March 13, 2023) — Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce that their co-funding agreement, which supports…
London, United Kingdom (Jan. 10, 2023) — Following promising results reported at Phase 2 in 2020, a large-scale Phase 3 clinical trial of ambroxol,…
This release has been republished from Cure Parkinson’s.
Researchers from Cedars Sinai Hospital, Los Angeles, have presented their initial top line results of…
As 2021 comes to a close, so too does Van Andel Institute’s celebration of our 25th anniversary. The Institute’s story began with a vision: to…
Drug repurposing program seeks to find treatments that slow or stop Parkinson’s progression and serve as a roadmap for similar initiatives in other…
LONDON (Sept. 21, 2020) — The Cure Parkinson’s Trust (CPT) and Van Andel Institute (VAI) are delighted to welcome a third strategic funding partner, The…
LONDON (Feb. 13, 2020) — The Cure Parkinson’s Trust (CPT) and Van Andel Institute (VAI) are delighted to announce a new three-year co-funding agreement that…
The Cure Parkinson's Trust (CPT) is delighted to announce the publication of the results of a Phase II clinical trial evaluating ambroxol as a…